4.8 Article

Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1621513114

关键词

nuclear receptors; drug discovery; structure-based design; peroxisome roliferator-activated receptor; cation-pi interaction

资金

  1. National Science Foundation [EEC-0813570]
  2. NIH [DK057978, HL105278, DK090962, HL088093, ES010337, CA014195]
  3. Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED-002]

向作者/读者索取更多资源

The peroxisome proliferator-activated receptor (PPAR) family comprises three subtypes: PPAR alpha, PPAR gamma, and PPAR delta. PPAR delta transcriptionally modulates lipid metabolism and the control of energy homeostasis; therefore, PPAR delta agonists are promising agents for treating a variety of metabolic disorders. In the present study, we develop a panel of rationally designed PPAR delta agonists. The modularmotif affords efficient syntheses using building blocks optimized for interactions with subtype-specific residues in the PPARd ligand-binding domain (LBD). A combination of atomic-resolution protein X-ray crystallographic structures, ligand-dependent LBD stabilization assays, and cell-based transactivation measurements delineate structure-activity relationships (SARs) for PPAR delta-selective targeting and structural modulation. We identify key ligand-induced conformational transitions of a conserved tryptophan side chain in the LBD that trigger reorganization of the H2'-H3 surface segment of PPARd. The subtype-specific conservation of H2'-H3 sequences suggests that this architectural remodeling constitutes a previously unrecognized conformational switch accompanying ligand-dependent PPAR delta transcriptional regulation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据